Prevalence and characteristics of HPV-driven oropharyngeal cancer in France.

[1]  M. Pawlita,et al.  Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania , 2018, PloS one.

[2]  S. Stoeckli,et al.  Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery , 2017, Head & neck.

[3]  M. Tommasino,et al.  Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years , 2017, Papillomavirus research.

[4]  S. Franceschi,et al.  Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study. , 2017, Oral oncology.

[5]  G. Launoy,et al.  Incidence trends for potentially human papillomavirus‐related and ‐unrelated head and neck cancers in France using population‐based cancer registries data: 1980–2012 , 2017, International journal of cancer.

[6]  R. Shaw,et al.  HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology. , 2016, Cancer research.

[7]  M. Pawlita,et al.  Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy , 2016, Papillomavirus research.

[8]  Shao Hui Huang,et al.  Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. , 2016, The Lancet. Oncology.

[9]  M. Poljak,et al.  Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983–2009: role of human papillomavirus infection , 2015, European Archives of Oto-Rhino-Laryngology.

[10]  A. Stec,et al.  Prevalence of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in south-eastern Poland , 2015, Infectious Agents and Cancer.

[11]  S. Kjaer,et al.  A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000–2010: The largest registry‐based study to date , 2015, International journal of cancer.

[12]  W. Weichert,et al.  Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. , 2015, European journal of cancer.

[13]  P. Snijders,et al.  Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990–2009) , 2014, International journal of cancer.

[14]  B. Pozzetto,et al.  Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications , 2013, Acta oto-laryngologica.

[15]  M. Rietbergen,et al.  Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm , 2013, International journal of cancer.

[16]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Clavel,et al.  Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  P. Sparén,et al.  Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma? , 2009, International journal of cancer.

[19]  P. Arapantoni-Dadioti,et al.  Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. , 2008, Anticancer research.

[20]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[21]  Jacques Ferlay,et al.  The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012 , 2017, CA: a cancer journal for clinicians.

[22]  D. Hartl,et al.  Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know. , 2014, Oral oncology.

[23]  W. De Neve,et al.  HPV-related oropharyngeal cancers in Flanders (Belgium): a multicenter study. , 2014, B-ENT.